J. Goldman & CO LP Merck & Co., Inc. Put Options Transaction History

J. Goldman & CO LP

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 14, 2024	BUY	$123.8 - $132.96 $12.4 Million - $13.3 Million	100,000 Added 166.67%	160,000 $19.8 Million
Q1 2024 May 15, 2024	BUY	$113.24 - $131.95 $5.1 Million - $5.94 Million	45,000 Added 300.0%	60,000 $7.92 Million
Q4 2023 Feb 14, 2024	SELL	$100.18 - $109.02 $8.65 Million - $9.41 Million	-86,300 Reduced 85.19%	15,000 $1.64 Million
Q3 2023 Nov 14, 2023	BUY	$102.95 - $114.33 $1.42 Million - $1.58 Million	13,800 Added 15.77%	101,300 $10.4 Million
Q2 2023 Aug 14, 2023	BUY	$108.61 - $118.38 $1.36 Million - $1.48 Million	12,500 Added 16.67%	87,500 $10.1 Million
Q1 2023 May 15, 2023	BUY	$102.94 - $114.86 $7.72 Million - $8.61 Million	75,000 New	75,000 $7.98 Million
Q2 2022 Aug 15, 2022	BUY	$83.49 - $94.64 $10.4 Million - $11.8 Million	125,100 New	125,100 $11.4 Million

3,819

1.88B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $247B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of J. Goldman & CO LP, based on Form 13F filings with the SEC.

Stay updated on J. Goldman & CO LP with notifications on news.